FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892054198> ?p ?o ?g. }

• W2892054198 endingPage "192" @default.
• W2892054198 startingPage "186" @default.
• W2892054198 abstract "Objectives Scientific literature about the combination of glucagon-like peptide-1 receptor agonists (GLP-1ra) and sodium-glucose cotransporter 2 (SGLT2) inhibitors in older patients is scarce. We sought to assess the real-world efficacy and safety of SGLT2 inhibitors and GLP-1ra combination therapy in older patients (>65 years of age). Methods This was an observational, prospective, multicenter study based on clinical practice. Patients were stratified according to tertiles of baseline glycated hemoglobin (A1C) levels and to treatment schedule. Results We included 113 patients (65.5% men, mean age 70.4±8.8 years). The body mass index was 36.5 (±6.6) kg/m2. The baseline A1C level was 8.0% (±1.2%). At the 6-month follow up, we found a significant reduction in A1C levels (–1.1%; p<0.0001), body mass index (–2.1 kg/m2; p<0.00003) and systolic blood pressure (–13 mmHg; p<0.000005). Patients who had the highest baseline A1C levels (≥8.4%) showed greater improvement in A1C levels (p<0.0001), weight (p<0.0001) and quality-of-life scores (p<0.0001). The greatest reduction in A1C levels and weight was seen in patients who started both drugs simultaneously (p<0.0001). The second greatest reduction was seen when GLP-1ra was added to previous treatment with an SGLT2i (p<0.0001). Also of note was a decrease in systolic blood pressure in patients for whom an SGLT2i was added to previous GLP-1ra treatment (p<0.0001). Of the patients, 34.3% achieved the combined endpoint of A1C levels <7% and weight loss ≥5% without hypoglycemia. Conclusions This study's findings provide evidence of clinically meaningful reductions in A1C level, body weight and systolic blood pressure in older patients with type 2 diabetes who are taking combined regimens. The dropout and hypoglycemia rates were minimal, and treatment was tolerated well." @default.
• W2892054198 created "2018-09-27" @default.
• W2892054198 creator A5002510504 @default.
• W2892054198 creator A5008334353 @default.
• W2892054198 creator A5014623904 @default.
• W2892054198 creator A5016358263 @default.
• W2892054198 creator A5018823100 @default.
• W2892054198 creator A5030506362 @default.
• W2892054198 creator A5037914704 @default.
• W2892054198 creator A5048840091 @default.
• W2892054198 creator A5086498053 @default.
• W2892054198 date "2019-04-01" @default.
• W2892054198 modified "2023-10-17" @default.
• W2892054198 title "Combination Therapy With Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients With Type 2 Diabetes: A Real-World Evidence Study" @default.
• W2892054198 cites W1920830047 @default.
• W2892054198 cites W1967442749 @default.
• W2892054198 cites W1973038508 @default.
• W2892054198 cites W1994222210 @default.
• W2892054198 cites W2007221722 @default.
• W2892054198 cites W2022936370 @default.
• W2892054198 cites W2029486004 @default.
• W2892054198 cites W2097128971 @default.
• W2892054198 cites W2110725041 @default.
• W2892054198 cites W2119697846 @default.
• W2892054198 cites W2124234371 @default.
• W2892054198 cites W2146264128 @default.
• W2892054198 cites W2150012656 @default.
• W2892054198 cites W2155965977 @default.
• W2892054198 cites W2161852973 @default.
• W2892054198 cites W2166613497 @default.
• W2892054198 cites W2168261002 @default.
• W2892054198 cites W2401267280 @default.
• W2892054198 cites W2412800896 @default.
• W2892054198 cites W2425644022 @default.
• W2892054198 cites W2475311184 @default.
• W2892054198 cites W2519510391 @default.
• W2892054198 cites W2519803668 @default.
• W2892054198 cites W2524109971 @default.
• W2892054198 cites W2586555700 @default.
• W2892054198 cites W2607109151 @default.
• W2892054198 cites W2626446274 @default.
• W2892054198 cites W2917198334 @default.
• W2892054198 cites W4213412326 @default.
• W2892054198 doi "https://doi.org/10.1016/j.jcjd.2018.09.001" @default.
• W2892054198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30415909" @default.
• W2892054198 hasPublicationYear "2019" @default.
• W2892054198 type Work @default.
• W2892054198 sameAs 2892054198 @default.
• W2892054198 citedByCount "15" @default.
• W2892054198 countsByYear W28920541982020 @default.
• W2892054198 countsByYear W28920541982021 @default.
• W2892054198 countsByYear W28920541982022 @default.
• W2892054198 countsByYear W28920541982023 @default.
• W2892054198 crossrefType "journal-article" @default.
• W2892054198 hasAuthorship W2892054198A5002510504 @default.
• W2892054198 hasAuthorship W2892054198A5008334353 @default.
• W2892054198 hasAuthorship W2892054198A5014623904 @default.
• W2892054198 hasAuthorship W2892054198A5016358263 @default.
• W2892054198 hasAuthorship W2892054198A5018823100 @default.
• W2892054198 hasAuthorship W2892054198A5030506362 @default.
• W2892054198 hasAuthorship W2892054198A5037914704 @default.
• W2892054198 hasAuthorship W2892054198A5048840091 @default.
• W2892054198 hasAuthorship W2892054198A5086498053 @default.
• W2892054198 hasConcept C126322002 @default.
• W2892054198 hasConcept C134018914 @default.
• W2892054198 hasConcept C2777180221 @default.
• W2892054198 hasConcept C2777538456 @default.
• W2892054198 hasConcept C2780221984 @default.
• W2892054198 hasConcept C511355011 @default.
• W2892054198 hasConcept C544821477 @default.
• W2892054198 hasConcept C555293320 @default.
• W2892054198 hasConcept C71924100 @default.
• W2892054198 hasConcept C84393581 @default.
• W2892054198 hasConcept C90924648 @default.
• W2892054198 hasConceptScore W2892054198C126322002 @default.
• W2892054198 hasConceptScore W2892054198C134018914 @default.
• W2892054198 hasConceptScore W2892054198C2777180221 @default.
• W2892054198 hasConceptScore W2892054198C2777538456 @default.
• W2892054198 hasConceptScore W2892054198C2780221984 @default.
• W2892054198 hasConceptScore W2892054198C511355011 @default.
• W2892054198 hasConceptScore W2892054198C544821477 @default.
• W2892054198 hasConceptScore W2892054198C555293320 @default.
• W2892054198 hasConceptScore W2892054198C71924100 @default.
• W2892054198 hasConceptScore W2892054198C84393581 @default.
• W2892054198 hasConceptScore W2892054198C90924648 @default.
• W2892054198 hasFunder F4320306257 @default.
• W2892054198 hasFunder F4320307770 @default.
• W2892054198 hasIssue "3" @default.
• W2892054198 hasLocation W28920541981 @default.
• W2892054198 hasLocation W28920541982 @default.
• W2892054198 hasOpenAccess W2892054198 @default.
• W2892054198 hasPrimaryLocation W28920541981 @default.
• W2892054198 hasRelatedWork W1964573677 @default.
• W2892054198 hasRelatedWork W1967894681 @default.
• W2892054198 hasRelatedWork W1978577632 @default.
• W2892054198 hasRelatedWork W2087665565 @default.
• W2892054198 hasRelatedWork W2114562309 @default.
• W2892054198 hasRelatedWork W2118878186 @default.

• next